Stryker Corporation (SYK)
NYSE: SYK · Real-Time Price · USD
394.22
+9.39 (2.44%)
At close: Aug 22, 2025, 4:00 PM
394.22
0.00 (0.00%)
After-hours: Aug 22, 2025, 4:10 PM EDT
Stryker Revenue
Stryker had revenue of $6.02B in the quarter ending June 30, 2025, with 11.07% growth. This brings the company's revenue in the last twelve months to $23.82B, up 11.36% year-over-year. In the year 2024, Stryker had annual revenue of $22.60B with 10.23% growth.
Revenue (ttm)
$23.82B
Revenue Growth
+11.36%
P/S Ratio
6.17
Revenue / Employee
$449,396
Employees
53,000
Market Cap
150.71B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 22.60B | 2.10B | 10.23% |
Dec 31, 2023 | 20.50B | 2.05B | 11.11% |
Dec 31, 2022 | 18.45B | 1.34B | 7.84% |
Dec 31, 2021 | 17.11B | 2.76B | 19.21% |
Dec 31, 2020 | 14.35B | -533.00M | -3.58% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
SYK News
- 3 days ago - Stryker Q2: Record Mako Installation And High Utilization - Seeking Alpha
- 3 days ago - Stryker: Strong Multi-Faceted Growth Continuing To Support The Shares - Seeking Alpha
- 7 days ago - Stryker to host investor day - GlobeNewsWire
- 8 days ago - Stryker to participate in the 2025 Wells Fargo Securities Healthcare Conference - GlobeNewsWire
- 15 days ago - Tim Scannell, Former Stryker President & COO, Named Chair of Longeviti Neuro Solutions Amid $10M Capital Infusion From Soleus Capital - GlobeNewsWire
- 15 days ago - Stryker declares an $0.84 per share quarterly dividend - GlobeNewsWire
- 21 days ago - Stryker Corporation (SYK) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Stryker raises annual profit forecast on steady demand for surgical devices - Reuters